Linked Color Imaging (LCI) for Colorectal Adenoma Detection
Linked Color Imaging (LCI) Versus Standard White-light Colonoscopy for Colorectal Adenoma Detection: a Multicenter, Randomized, Trial
1 other identifier
interventional
600
1 country
1
Brief Summary
Linked color imaging (LCI) is newly developed image-enhancing endoscopy technology that differentiates the red color spectrum more effectively than white light imaging thanks to its optimal pre-process composition of light spectrum and advanced signal processing. This technology, combined in the latest generation Fujifilm's endoscopes (Fujifilm Co, Tokyo, Japan) with new high-performance LED illumination system, enhances the visibility of colonic mucosal vessels and might increase the detection rate of colorectal polyps. Data available regarding colorectal polyp or adenoma detection with LCI are encouraging but are scanty and limited to back-to back studies. This two parallel arms, randomized, multicenter trial is aimed at evaluating whether LCI is superior to WL endoscopy in terms of adenoma detection
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 18, 2018
CompletedFirst Posted
Study publicly available on registry
October 1, 2018
CompletedStudy Start
First participant enrolled
October 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 21, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2019
CompletedOctober 2, 2019
October 1, 2019
8 months
September 18, 2018
October 1, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adenoma Detection Rate
proportion of participants with at least one adenoma (per-patient analysis)
1 year
Secondary Outcomes (3)
advanced adenoma detection rate
1 year
mean number per subject of polyps, adenomas, advanced adenomas and sessile serrated lesions
1 year
Withdrawal time
1 year
Study Arms (2)
LCI
EXPERIMENTALLinked Color Imaging
WL
ACTIVE COMPARATORWhite Light
Interventions
Use of narrow band imaging with LCI for colon inspection during both insertion and withdrawal phase of colonoscopy
Eligibility Criteria
You may qualify if:
- years-old subjects participating in the regional screening program undergoing their first colonoscopy following a positive immunochemical fecal occult blood test (FIT)
You may not qualify if:
- subjects not eligible for invitation in the screening program (colonoscopy already performed in the previous 5 years, personal history of CRC, colonic adenomas or IBD, severe comorbidity, including end-stage cardiovascular, pulmonary, liver or renal disease)
- patients with inadequate bowel preparation (defined as Boston Bowel Preparation Scale \> 2 in any colonic segment)
- patients with previous colonic resection
- patients on antithrombotic therapy, precluding polyp resection
- patients who were not able or refused to give informed written consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Valduce Hospitallead
Study Sites (1)
Gastroenterology Unit, Valduce Hospital
Como, 22100, Italy
Related Publications (1)
Paggi S, Radaelli F, Senore C, Maselli R, Amato A, Andrisani G, Di Matteo F, Cecinato P, Grillo S, Sereni G, Sassatelli R, Manfredi G, Alicante S, Buscarini E, Canova D, Milan L, Pallini P, Iwatate M, Rondonotti E, Repici A, Hassan C. Linked-color imaging versus white-light colonoscopy in an organized colorectal cancer screening program. Gastrointest Endosc. 2020 Sep;92(3):723-730. doi: 10.1016/j.gie.2020.05.044. Epub 2020 Jun 2.
PMID: 32502550DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Franco Radaelli, MD
Valduce Hospital, Como
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Head Endoscopy Unit, Valduce Hospital
Study Record Dates
First Submitted
September 18, 2018
First Posted
October 1, 2018
Study Start
October 15, 2018
Primary Completion
June 21, 2019
Study Completion
September 1, 2019
Last Updated
October 2, 2019
Record last verified: 2019-10